News & Trends - Pharmaceuticals

First Australian site joins AstraZeneca's phase 3 breast cancer trial

First Australian site joins AstraZeneca’s phase 3 breast cancer trial

Health Industry Hub | November 21, 2024 |

Australia’s first site joins an international breast cancer clinical trial aimed at determining whether AstraZeneca’s next-gen hormone treatment can provide […]

More

News & Trends - MedTech & Diagnostics

Australians lack trust in politicians and mainstream media as ethics index hits new low

Australians lack trust in politicians and mainstream media as ethics index hits new low

Health Industry Hub | November 21, 2024 |

Australians have ranked health as the most ethical sector (64) and mainstream broadcast media as the least ethical (–10), according […]

More

News & Trends - Biotechnology

First national summit calls for unified strategy to reshape local biotech and medtech sectors

First national summit calls for unified strategy to reshape local biotech and medtech sectors

Health Industry Hub | November 19, 2024 |

The National Biotech and Medtech Development and Commercialisation Summit 2024 convenes today in Canberra, bringing together over 100 of Australia’s […]

More

Digital & Innovation

AI partnership to propel launch of National Lung Cancer Screening Programme

AI partnership to propel launch of National Lung Cancer Screening Programme

Health Industry Hub | October 22, 2024 |

Digital & Innovation: Starting July 2025, the Australian Government will fund the National Lung Cancer Screening Programme (NLCSP), a crucial […]

More

Leadership & Management

Lundbeck appoints new Managing Director in ANZ

Lundbeck appoints new Managing Director in ANZ

Health Industry Hub | November 8, 2024 |

Leadership & Management: Lundbeck has named Cara Dignum as the new Managing Director for Lundbeck Australia and New Zealand, succeeding […]

More

ESG

Edwards Lifesciences VP challenges us to 'dream bigger' for underserved communities

Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities

Health Industry Hub | November 11, 2024 |

Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]

More

Human Resources

Women still earn $28K less than men despite progress

Women still earn $28K less than men despite progress

Health Industry Hub | November 20, 2024 |

Australia’s total remuneration gender pay gap has narrowed by 0.6 percentage points, with more employers analysing and addressing the underlying […]

More

Medical and Science

Former health official appointed to lead new strategy as Research Australia and STA warn of key gaps

Former health official appointed to lead new strategy as Research Australia and STA warn of key gaps

Health Industry Hub | November 18, 2024 |

Former deputy secretary of the Department of Health, Rosemary Huxtable AO PSM, has been appointed to spearhead the development of […]

More

Communication

Australians trust in mainstream health media is in crisis

Australians’ trust in mainstream health media is in crisis

Health Industry Hub | July 1, 2024 |

Despite several mainstream media journalists being recognised at the 2024 Excellence in Health Journalism Awards by Rare Cancers and Prospection […]

More

Marketing & Strategy

Bayer, MSD and Takeda among winners at Asia Pacific awards

Bayer, MSD and Takeda among winners at Asia Pacific awards

Health Industry Hub | March 28, 2024 |

Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]

More

Latest News in Pharma, MedTech, Diagnostics & Biotech

First Australian site joins AstraZeneca’s phase 3 breast cancer trial
By Health Industry Hub
November 21, 2024 in News & Trends - Pharmaceuticals

Australians lack trust in politicians and mainstream media as ethics index hits new low
By Health Industry Hub
November 21, 2024 in News & Trends - MedTech & Diagnostics

Amgen secures PBS listing for the only dual-action first-line therapy in osteoporosis
By Health Industry Hub
November 21, 2024 in News & Trends - Pharmaceuticals

Aussie researchers expand high cholesterol treatments with game-changing data unveiled on global stage
By Health Industry Hub
November 21, 2024 in News & Trends - Pharmaceuticals

Health Minister announces HTA reform advisory group as questions persist over timelines and transparency
By Health Industry Hub
November 20, 2024 in News & Trends - Pharmaceuticals

Fix it once and for all: Viatris country manager calls for action on medicine shortages and sovereign manufacturing
By Health Industry Hub
November 20, 2024 in News & Trends - Pharmaceuticals

Australia risks missing $1 billion windfall without biosimilar action
By Health Industry Hub
November 20, 2024 in News & Trends - Pharmaceuticals

Women still earn $28K less than men despite progress
By Health Industry Hub
November 20, 2024 in Human Resources

Government urged to prioritise prevention as chronic disease costs surge by $13 billion
By Health Industry Hub
November 20, 2024 in News & Trends - Pharmaceuticals

Boston Scientific unveils superiority data in bleeding risk reduction post-cardiac ablation
By Health Industry Hub
November 19, 2024 in News & Trends - MedTech & Diagnostics

Getz Healthcare signs distribution agreement for electrochemotherapy technology
By Health Industry Hub
November 19, 2024 in News & Trends - MedTech & Diagnostics

Will the BMS Summit challenge government to act on HTA reforms amid competing priorities?
By Health Industry Hub
November 19, 2024 in News & Trends - Pharmaceuticals

First national summit calls for unified strategy to reshape local biotech and medtech sectors
By Health Industry Hub
November 19, 2024 in News & Trends - Biotechnology

‘Government’s broken promises in the health portfolio are piling up,’ says Shadow Health Minister Ann Ruston
By Health Industry Hub
November 18, 2024 in News & Trends - Pharmaceuticals

Boston Scientific acquires Medtronic’s neuromodulation competitor
By Health Industry Hub
November 18, 2024 in News & Trends - MedTech & Diagnostics

Doctors accused of fraudulent billing while health insurers pocket record profits
By Health Industry Hub
November 18, 2024 in News & Trends - MedTech & Diagnostics

Former health official appointed to lead new strategy as Research Australia and STA warn of key gaps
By Health Industry Hub
November 18, 2024 in Medical and Science

Aussie biotech nabs award for needle-free vaccine technology
By Health Industry Hub
November 18, 2024 in News & Trends - Biotechnology

Horizon scanning report exposes critical systemic gaps demanding immediate reform
By Health Industry Hub
November 15, 2024 in News & Trends - Pharmaceuticals

  • Follow Us

  • Partner with us

    Build thought leadership, differentiate your organisation and let us help you connect with Pharma, MedTech, Diagnostics and Biotech industry professionals.

    To find out how you can engage with Health Industry Hub’s audience click here.

  • News & Trends - Pharmaceuticals

    First Australian site joins AstraZeneca's phase 3 breast cancer trial

    First Australian site joins AstraZeneca’s phase 3 breast cancer trial

    Health Industry Hub | November 21, 2024 |

    Australia’s first site joins an international breast cancer clinical trial aimed at determining whether AstraZeneca’s next-gen hormone treatment can provide […]

    More


    News & Trends - MedTech & Diagnostics

    Australians lack trust in politicians and mainstream media as ethics index hits new low

    Australians lack trust in politicians and mainstream media as ethics index hits new low

    Health Industry Hub | November 21, 2024 |

    Australians have ranked health as the most ethical sector (64) and mainstream broadcast media as the least ethical (–10), according […]

    More


    News & Trends - Pharmaceuticals

    Amgen secures PBS listing for the only dual-action first-line therapy in osteoporosis

    Amgen secures PBS listing for the only dual-action first-line therapy in osteoporosis

    Health Industry Hub | November 21, 2024 |

    Amgen’s humanised monoclonal antibody has become the first osteoanabolic agent with a dual mode of action to be listed on […]

    More


    News & Trends - Pharmaceuticals

    Aussie researchers expand high cholesterol treatments with game-changing data unveiled on global stage

    Aussie researchers expand high cholesterol treatments with game-changing data unveiled on global stage

    Health Industry Hub | November 21, 2024 |

    Monash University and Monash Health are collaborating on two clinical trials to develop the first effective drug treatments for two […]

    More


    This content is copyright protected. Please subscribe to gain access.